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Summary 
Chromosomal anomaly is an abnormality of the number or structure of the chromosome. 
Based on this, they are classified as either numerical or structural. These anomalies can 
have a mild or severe effect on the phenotype of the carrier which depends on the 
chromosomal region involved and the genes implicated. They can be sporadic or 
inherited. Thus, it is essential to investigate such anomalies both prenatally and 
postnatally alike. In a standard cytogenetic lab, these anomalies can be detected using 
low-resolution or high-resolution karyotype, usually by performing GTG (G-bands by 
trypsin using Giemsa) on chromosomes undergoing mitosis, derived from blood. If higher 
resolution is required, there are various other molecular cytogenetic techniques available 
like FISH and microsatellite analysis. More recently, microarrays have opened a new era 
in the field of molecular genetics by greatly increasing the resolution of screening for 
copy number gains and losses. Using these techniques, we characterized deletions in the 
long arm of chromosome 7 in three clinical cases, identified the breakpoint, studied the 
inheritance pattern and compared our cases with the other cases carrying similar deletion 
in the literature. It was observed that the deletion was located at 7q36.2, 7q35 and 7q36.1 
for cases 1, 2 and 3 respectively. Case 3 also carried a duplication of Xq28. 
Key W o r d s 
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Preface 
Chromosome abnormalities occur with a frequency estimated to be about 10-30% of all 
fertilized eggs. Of the different types of chromosome abnormalities, aneuploidy (trisomy 
and monosomy) is considered to be the most common and, clinically, the most important. 
Over 25% of miscarriages are due to monosomy or trisomy, making aneuploidy one of 
the leading causes of pregnancy loss (Hassold et al., 1996). 
In addition, terminal deletion or partial monosomy of a chromosomal region often results 
in significant pathology like mental retardation, growth delay, cleft lip and palate etc. 
Therefore it is essential to investigate such cases and establish a genotype-phenotype 
correlation, such that proper diagnosis and care can be provided. 
The main project during my Master's was investigation of three patients with deletion of 
the long arm of chromosome 7 (7q). Characterization of the deletion and its association 
with the patient's phenotype was done using cytogenetic and molecular genetic 
techniques. These techniques were performed by me except for the array-CGH (all cases), 
that was done at GeneDx. 
I wrote the initial draft of the paper under the guidance of Mr. Macoura Gadji, who is the 
second author of the article. 
This article has never been a part of any other thesis and is only included in my thesis, I 
being the first author. 
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Dr. Sylvie Cote and Dr. Kada Krabchi are the doctors who investigated patient 1. Dr. 
Bruno Maranda and Dr. J. Gekas are the doctors who clinically investigated the patients 2 
and 3 in Quebec. 
Addendum: 
Before working on the three patients described above, I was involved in various parts of 
the fetal cell project for my training in the laboratory. The aim of the fetal cell project is 
to be able to detect aneuploidy in the fetus in a manner that is non-invasive, since the 
invasive techniques like amniocentesis and chorionic villus sampling pose a certain risk 
to the fetus. This is made possible by the presence of fetal cells found in maternal 
peripheral blood (Herzenberg et al., 1979; Walknowska et al., 1969). Quantification of 
these fetal cells by targeting XY cells using FISH and PRINS in normal and abnormal 
male pregnancies has been carried out in our lab by Dr. Kada Krabchi by manual 
scanning. It was observed that approximately 2-6 fetal cells are present per ml of 
maternal blood (Krabchi et al., 2001) and the number seemed to increase in cases of 
aneuploidy (Krabchi et al., 2006a; Krabchi et al., 2006b). Therefore, to spot these 2 to 6 
cells (using Y as marker chromosome) among millions of XX cells, by manual scanning 
is a technical challenge. 
Thus, we worked on validating Ikoniscope- an automatic slide scanning apparatus for 
detecting rare XY cells among thousands of XX cells. In this project, I did not work on 
real cases from pregnant women but simulated a similar condition by taking blood from 
normal male and female persons and harvesting it using standard procedure, spreading 1-
X I I 
2 XY cells on clean slides under optimal conditions, counting, imaging and taking 
coordinates of these cells and finally spreading XX cells on top of them. This was 
followed by FISH with X in SO and Y in SG. The slides were then loaded on the 
Ikoniscope for automatic scanning and the pictures taken by the machine were analyzed 
and classified as true or false positive. The advantage of this protocol was that we already 
knew the number of XY cells on the slide and we could compare the XY cells spread by 
us and the number of cells retrieved by the Ikoniscope. 
In the part described above, I worked on harvesting of blood, spreading XY and XX cells 
on slide, counting and imaging XY cells before spreading XX on top of it, cross checked 
by another student, doing FISH, analyzing pictures on Ikoniscope, going back to the cells 
missed by the Ikoniscope manually on the microscope and investigating the reason why 
the cells were missed. 
Since manual scanning of rare events has never been validated we followed the same 
protocol for validation of manual scanning. The slides were scanned manually instead of 
automatically by me and another student in the lab. 
Getting involved in this project taught me various techniques like, blood harvest, FISH, 
recognizing a FISH signal, differentiating between a false positive and a true positive and 
spreading very few (1-10) cells on a slide. 
For validation of manual scanning, I was involved in counting and imaging XY cells prior 
to spreading XX cells cross counted by another student. I also manually scanned slides in 
this part. 
X I I I 
Other goal of this project was to establish a technique that was the best for detecting rare 
events among FISH, PRINS and PNA-FISH. Consequently, this was followed by 
improvement of the PRINS technique for comparison with other techniques. I tried 
various different protocols to optimize the technique. Thus, it exposed me to different 
useful parameters of research. 
X I V 
1. INTRODUCTION 
1.1) Definition and History 
Genetics is the branch of biology that deals with the study of heredity. The hereditary 
nature of living organisms is defined by their genome which consists of nucleic acid. 
Deoxyribonucleic acid (DNA) is the raw material of inheritance in humans and is 
functionally divided into genes and produces proteins essential for life. A very long 
molecule of DNA along with the associated proteins comprises a chromosome. The study 
of structure, function and evolution of chromosomes is referred to as cytogenetics. 
Human cytogenetics had its beginning in the nineteenth century. The term "chromosome" 
was first introduced in 1888 which means colored body in Greek (Waldeyer 1888). The 
number of chromosomes in a normal human was corrected to 46 in 1956 (Tjio 1956), 
(Ford et al., 1956), it was considered to be 48 since 1923. 
Soon clinical cytogenetics emerged. It deals with the cellular aspects of heredity, 
especially the chromosomes, to diagnose medical conditions (mental retardation, multiple 
malformations, cancer) caused by genomic aberrations. These aberrations are a result of 
an abnormal structure or number of chromosomes. The first chromosome abnormality 
described in human was Down syndrome. Lejeune et al. found that Down syndrome is 
caused by the presence of three copies of chromosome 21 (trisomy 21) instead of the 
usual two copies (Lejeune et al., 1959a; Lejeune et al., 1959b). 
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Detailed studies of human chromosomes became possible only after several technical 
developments. Peter Nowell in 1960, observed that the kidney bean extract 
phytohemagglutinin, stimulated lymphocytes to divide (Nowell 1960). Consequently 
chromosome studies could be carried out much more easily. The introduction of 
chromosome banding revolutionized human cytogenetics in the following years. Over the 
past 25 years molecular cytogenetic techniques of increasingly high-resolution have been 
developed. 
1.2) Chromosome 
1.2.1) Compaction and Packaging 
A chromosome is made up of chromatin which is a highly structured complex of DNA 
and various histone and nonhistone proteins. The DNA is five to ten times more 
condensed in metaphase chromosomes than in interphase chromatin. The DNA double 
helix is 2 nm in diameter and is wound around proteins. Histones are low molecular 
weight basic proteins that have high-binding affinity for DNA. The DNA is wound 
around a protein disk consisting of histones H2A, H2B, H3, and H4. The centre of the 
disk consists of two molecules each of H3 and H4 and each of the faces consisting of an 
H2A-H2B complex. The DNA is wound twice around the histone octamer to form a 
nucleosome core. The two coils of DNA, containing 146 bp are compacted into 5.7 nm, 
which is the thickness of histone disk. Nucleosome cores are connected through DNA 
linkers of 90-100 bp. A nucleosome thus consists of the core and linker containing about 
200 bp of DNA. The nucleosome represents the first level of packaging. When chromatin 
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is dispersed, the chromosome strands appear in electron micrograph as 11 nm disk like 
beads on a DNA string {Figure 1). Single molecules of histone 1 (HI) attach to the 
nucleosomes at the position of the linkers. 
DNA double helix 
' hf;u<s on i» sftiiKj" " 
form til chromatin <• 
30 nm chromatin 
fibw ni |h« k«d 
nutleosomes 
MH'timi of 
i l!r<irm>«»tTM5 m 
cttmtertsed setfton 
of chromosome 
tnmrts 
r ittoTfC 
rhroHUjsofne 
Figure 1: Different levels of chromatin packaging (Figure 4-55, Alberts et al„ Molecular Biology 
of the cell, 2002) (Alberts et al., 2002). 
This twists the successive nucleosome cores in to a 30-nm fiber, producing another six-
fold DNA compaction. The next level of packing leads to the formation of thicker fiber, 
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130-300 nm. This structure is made of loops, called domains. DNA and histones make up 
about two-third of the chromosome mass; the rest is made up by mostly nonhistone 
proteins. These proteins include various HMG (high-mobility-group) proteins, and a few 
rather insoluble scaffold proteins, which make up about 5% of the chromosome mass. 
Above the level of 30-nm fiber, chromatin is constrained by scaffold proteins into loop 
domains. Thereafter, several levels of structure are formed in a similar manner to a more 
condensed state, to yield the highest level of compaction, the metaphase chromosome. 
1.2.2) Structure 
A typical replicated metaphase chromosome consists of two sister chromatids (Figure 2), 
which becomes daughter chromosomes after its separation at anaphase. Each chromatid 
has two arms separated by a centromere, the site of spindle microtubule attachment. 
Mitotic spindle fibers are the functional elements that separate the sister chromatids 
during cell division. Each chromosome has a characteristic length (l-10|im or so) and 
position of the centromere which divides the chromosome into short arm, designated as p 
arm, and long arm, designated as q arm (Paris conference 1971) (Figure 2). The physical 
ends of the chromosome are capped by telomeres that contain short TTAGGG repeats 
and proteins. Telomeres protect the chromosome ends from end-to-end fusion. 
According to the position of the centromere and relative lengths of p and q arm, the 
chromosome can be classified as- metacentric, sub-metacentric, acrocentric, or telocentric 
(Figure 3). Metacentric chromosomes have the centromere near the middle, 
4 
submetacentric chromosomes have the centromere so placed that it divides the 
chromosome into two arms of unequal length (p arm being short and q being long), 
acrocentric chromosomes have it located quite near one end of the chromosome, and 
telocentric chromosomes have centromeres at the end. Telocentric chromosomes do not 
exist in normal humans and are found only as a result of a structural change. 
DNA double helix 
Chromosome— 
p arm 
Centromere 
q arm 
Histone prote ins^ 
'W 
DNA 
/ ' ' 
' t • fli 
U-1?. H.ttk fMl ts&eaiy at Madiclna ^ 
http://ghr.nlm.nih.gov/handbook/illustrations/chromosomestructure.jpg 
.il •,<fr 
Figure 2: A condensed metaphase chromosome with highly compact DNA coiled around 
proteins. 
Centromeric position and arm lenath 
I 
inttJc Subjnotacontric Acre 
0 
conMc ToJocenMc 
http://www.obgynacademy.com/basicsciences/fetology/genetics/images/centpos.gif 
Figure 3: Metacentric, submetacentric, acrocentric and telocentric chromosomes. 
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The study of chromosomes is important in understanding etiology of mental retardation, 
multiple malformation, cancer, infertility and spontaneous abortion which could be a 
manifestation of underlying genetic anomaly. It is therefore essential to study whether or 
not there are any kinds of genomic aberration involved. 
1.3) Genomic Aberrations can be classified as follows-
1.3.1) Single gene disorders 
1.3.2) Multifactorial disorders 
1.3.3) Chromosome abnormality 
1.3.1) Single gene disorders - These disorders are caused by mutations or defects in 
single gene e.g. - Thalassemias, Huntington disease. 
1.3.2) Multifactorial disease - The disease is a result of a combination of small 
variations in genes that together produce a serious defect often concert with 
environmental factors and lifestyle e.g.- Diabetes type 2. 
1.3.3) Chromosome abnormality is an anomaly in the normal structure or number of 
chromosome(s). It is of two types. If it reflects an abnormality in the chromosome 
number it is Numerical, while an aberration in the structure of the chromosome is 
called a Structural anomaly. These abnormalities usually occur when there is an 
error in cell division following meiosis or mitosis. They can also occur due to 
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several mutations caused by DNA damaging agents like UV rays. They can be 
acquired during lifetime (de novo) or inherited. 
1.3.3.1) Numerical anomaly is classified as - Aneuploidy and Polyploidy. 
1.3.3.1.1) Aneuploidy- The occurrence of one or more extra or missing 
chromosome(s) (Figure 4) leading to an unbalanced chromosome 
complement. It is mostly caused by an error in cell division. This mainly leads 
to trisomy or monosomy of the chromosome. 
r ' 
V J 
Homologous 
pair of chrom-
osomes (b) 
Monosomy 
(c) 
Figure 4: A normal homologous pair of chromosomes (b), three 
copies of the chromosome (trisomy) (a), one copy of the chromosome 
(monosomy) (c). 
1.3.3.1.2) Polyploidy- Cells are polyploid if they contain more than two 
haploid (n) sets of chromosomes. For example, triploid (3n) (Figure 5) and 
tetraploid (4n) cells. Most polyploid embryos die early in pregnancy and are 
spontaneously aborted. 
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http://www.asklenore.info/iriiscarriage/print/images/fig3.jpg 
Figure 5: An extra copy of each chromosome is present resulting in an extra 
haploid set of chromosomes (triploidy). 
1.3.3.2) Structural anomaly is further classified as - Insertion, duplication, 
inversion, ring, translocation and deletion. 
1.3.3.2)1. Insertion- It is the insertion of a chromosomal segment into 
another chromosome. This results in extra genetic material and can cause 
deleterious phenotypes in the carrier. The segments L, K have been 
inserted in between segments E and F (Figure 6). 
http://trc.ucdavis.edu/bioscil0v/bisl0v/week4/dupiicationpic.gif (modified) 
Figure 6: An Insertion. 
8 
1.3.3.2)2. Duplication- A portion of the chromosome is duplicated, 
resulting in extra genetic material (Figure 7). The segments D, E are 
repeated once and thrice in the two chromosomes below. This results in 
extra chromosomal material. 
http://trc.ucdavis.edu/bioscil0v/bisl0v/week4/duplicationpic.gif 
Figure 7: A Duplication. 
1.3.3.2)3. Inversion- A portion of the chromosome breaks off, turns 
upside down and reattaches, thus the genetic material is inverted. The 
segment GHI, has been inverted to IHG (Figure 8). Inversions are either 
pericentric (centromere involved) or paracentric (centromere not 
involved). 
Fig. 1.8 is an example of paracentric inversion. 
http://trc.ucdavis.edu/bioscilOv/bislOv/week4/inversion.gif 
Figure: 8: An Inversion. 
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1.3.3.2)4. Ring- A portion of the chromosome breaks off, the sticky ends 
come together and join to form a circle or ring. 
Note the two chromosome ends break and the sticky ends join to form a 
ring chromosome in the figure below (Figure 9). 
Broken end 1 Dysfunctional telomere 
1 
Broken end ^ Dysfunctional telomere 
http://gurfein.com/cubby/images/rings.gif 
Figure 9: Ring chromosome. 
1.3.3.2)5. Translocation- A chromosome translocation is a chromosome 
abnormality caused by a rearrangement of parts between two non-
homologous chromosomes. This is classified as reciprocal or 
robertsonian. Reciprocal is further divided as balanced and unbalanced. 
1.3.3.2)5.1.1 Balanced reciprocal translocation- When there is no net 
loss or gain of genetic material due to a rearrangement between two non-
homologous chromosomes, it is called a balanced translocation (Figure 
10). 
1 0 
Before translocation After translocation 
Chromosome 2 0 
Derivative 
Chromosome 2 0 
f * J 
Derivative 
Chromosome 4 
Chromosome 4 
http://www.genome.gov/Pages/Hyperion/DIR/VIP/Glossarv/lllustration/lmages/translocation.gif 
Figure 10: A balanced translocation between chromosome 4 
1.3.3.2)5.1.2 Unbalanced reciprocal translocation- When there is a net 
loss or gain of genetic material due to a rearrangement between two non-
homologous chromosomes, it is called an unbalanced translocation. Shown 
in the figure is a reciprocal unbalanced translocation between chromosome 
4 and 20. The extra genetic material on the derived chromosome 20 
attributes to an unbalanced translocation. (Figure 11). 
1.3.3.2).5.2 Robertsonian translocation- Robertsonian translocation is a 
common form of chromosomal rearrangement that occurs between two 
acrocentric chromosomes (Figure 12). It is formed by fusion of the whole 
and 20. 
1 1 
long arms of two acrocentric chromosomes. Breaks may also occur in one 
short arm and one long arm. 
B e f o r e t r a n s l o c a t i o n A f t e r t r a n s l o c a t i o n 
C h r o m o s o m e 2 0 C h r o m o s o m e 2 0 
a 
C h r o m o s o m e 4 C h r o m o s o m e 4 
http://www.genome.gov/Pages/Hyperion/DIR/VIP/Glossarv/lllustration/lmages/translocation.gif (modified) 
Figure 11: An unbalanced reciprocal translocation. 
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https://images2.clinicaltools.com/images/gene/13_14_derivative.jpg 
Figure 12: A robertsonian translocation. 
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1.3.3.2)6. Deletion- Deletion is a structural anomaly where a part of the 
chromosome is lost/deleted resulting in loss of genetic material. 
1.3.3.2)6.1. Interstitial deletions occur when a middle portion of the 
chromosome gets deleted. It arises if there are two breaks in the same arm 
of the chromosome. The segment C is deleted resulting in an interstitial 
deletion (Figure 13). 
http://trc.ucdavis.edu/bioscil0v/bisl0v/week4/deletion.gif 
Figure 13: An interstitial deletion. 
1.3.3.2)6.2. If the loss of the chromosomal segment is due to a single 
break it results in a terminal deletion. The segment J is deleted at the end 
of the long arm of the chromosome giving rise to a terminal deletion 
(Figure 14). 
http://trc.ucdavis.edu/bioscil0v/bisl0v/week4/deietion.gif (modified) 
Figure 14: A terminal deletion. 
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These genetic aberrations are studied using following cytogenetic and molecular genetic 
tools. 
1.4) Standard cytogenetic techniques- Conventional or standard cytogenetic 
techniques are the basic techniques used in laboratories for many years for chromosome 
analysis. These techniques have wide applications, from clinical diagnostics to basic 
genomic research. 
1.4.1) Cell Culture- Actively dividing cells are required for studying chromosomes 
using traditional cytogenetic techniques. Specimens (blood, amniotic fluid, skin 
fibroblasts) for chromosome preparation are grown and maintained in an aqueous growth 
medium. For solid tissues like skin biopsy, the tissue must be disaggregated before 
culture, and only a drop of medium is added on each piece so that the biopsy attaches on 
the surface and the cells start dividing. 
Blood culture- Some cells, particularly lymphocytes do not undergo cell division 
and must be stimulated to divide by addition of a mitogen. The cell division is 
accelerated by adding PHA (phytohaemaglutinin). After setting-up of culture, 
once the requirements are met, the cells are allowed to grow under optimal 
conditions for an appropriate time. This time depends on the kind of cell involved. 
Subsequently, the dividing cells are collected at metaphase. A mitotic inhibitor is 
used to obtain adequate number of cells in metaphase. Colcemid binds to the 
protein tubulin and obstructs formation of spindle fibers preventing separation of 
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sister chromatids at the anaphase. However, in such mitosis the chromosomes are 
very short and condensed. Subsequently, cell synchronization methods were 
developed where cells are harvested at late prophase rather than metaphase. This 
is essential for high-resolution cytogenetics. It can be achieved by adding an 
excess of thymidine, methotrexate, 5-fluorodeoxyuridine (FdUrd), 5-bromo-2'-
deoxyuridine (BrdUrd). These compounds inhibit DNA synthesis by disturbing 
the de novo synthesis of one pyrimidine base, thus blocking at the S-phase 
(Drouin et al., 1994). After synchronization, inhibition can be released by washing 
out the inhibitor. Hence, by performing each step at the right time, a good quantity 
of cells in late prophase to prometaphase can be harvested. After release of the 
cells they are given hypotonic shock to swell the cells. This is followed by 
fixation; the fixative must be freshly prepared to obtain good chromosome quality. 
Fixed cells from suspension are dropped onto clean slides under optimal 
temperature and humidity. Later the slides are aged overnight at 60°C for 
chromosome banding. 
A large number of banding and staining techniques have been developed. On the basis of 
the unique banding pattern of each pair of chromosomes, they are identified and classified 
according to the nomenclature. This classification was set up in 1960, at the Denver 
Conference, by a group of cytogeneticists and has been upgraded since then in the 
following conferences of the ISCN (International System for Human Cytogenetic 
Nomenclature). 
1.4.2) Banding- Differentially stained regions produced on a chromosome as a result of 
treatment with chemicals and dyes is referred to as a "band". Chromosome banding can 
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be morphologic (structural) and dynamic (replication) (Drouin et al., 1994). 
Morphological banding is the result of the chemical heterogeneity that exists along the 
length of the chromosome. Dynamic banding on the other hand relies on the incorporation 
of a base analog, usually BrdUrd, into DNA during the synthesis phase. 
Another classification divides the banding techniques into two groups: (a) those that 
result in the distribution of bands on the entire length of chromosome, such a G, Q, and 
R-bands, and (b) those that stain specific chromosome structures. These methods reveal 
constitutive heterochromatin (highly compact, late-replicating, genetically inactive), like 
C-Bands (centromere), T-Bands (telomere) andNORs (nucleolus organizing regions). 
1.4.2.1) Q-Banding- Q-banding was the first banding method developed for human 
chromosomes (Caspersson et al., 1968; Caspersson et al., 1970). Certain fluorochromes, 
such as quinacrine dihydrochloride, bind to DNA and produce banding patterns of bright 
and dull fluorescence when excited with proper wavelength of light. The A-T rich sites 
are brightly fluorescing regions. 
1.4.2.2) G-Banding- Giemsa banding replaced Quinacrine banding in the 1970s. G-
banding is the most widely used method in cytogenetic laboratories; GTG (G-bands by 
trypsin using Giemsa) is most common. Prepared and aged slides are treated with the 
enzyme trypsin and then stained with Giemsa producing light and dark bands (Figure 
15). The G-bands that correspond to the bands darkly stained after GTG banding, are late 
replicating (Comings 1978), G-C poor (Cuny et al., 1981), heterochromatic regions of 
chromosomes, while the R-bands that correspond to the bands lightly stained after GTG 
banding are early replicating, G-C rich, euchromatic regions. Each chromosome after 
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staining consists of a continuous series of dark and light bands. Chromosomes are then 
arranged according to their banding pattern. The bands and regions are numbered from 
the centromere outward (Figure IS). A band is further subdivided in to sub-bands 
depending on the resolution. A region is defined as an area of chromosome lying between 
two adjacent landmarks. Landmarks are consistent and distinct morphological features 
important in identifying chromosomes. For example 7q31.1 means chromosome 7, long 
arm, region 3, band 1, sub-band 1 in that order. Figure: 16a, b, c and d, shows GTG 
performed on the three cases that were studied by us. 
http://www.genet.sickkids.on.ca/chromosome7/ (modified) 
Figure 15: Idiogram of G-banding pattern for normal human chromosome 7 at 
approximately 550 band level. Indicated with orange is a sub-band, with blue is a band 
and with red is a region. 
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Figure 16a: High-resolution karyotype of patient 1. 
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Figure 16b: Low-resolution karyotype of patient 1. 
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Figure 16c: Low-resolution karyotype of patient 2. 
Figure 16d: Low-resolution karyotype of patient 3. 
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1.4.2.3) R-Banding- R-banding is the reverse of G-banding. It was discovered by 
Dutrillaux and Lejeune (Dutrillaux et al., 1971). R morphological bands can be obtained 
by thermal denaturation of chromosomes. Indeed, R-bands are less sensitive to heat and 
can be stained using Giemsa to be viewed (Richer et al., 1983). R-bands replicate early 
(Comings 1978) and are GC rich (Cuny et al., 1981). 
1.4.2.4) C-Banding- C-banding techniques stain the constitutive heterochromatic regions 
around the centromeres. C-band regions contain highly repetitive, late replicating 
sequences of DNA. 
1.4.2.5) T-Banding- T-banding involves staining only the telomeres of the chromosomes. 
1.4.2.6) NOR Staining- This technique selectively stains the nucleolar organizer regions 
located on satellite stalks of acrocentric chromosomes. NOR staining is useful in 
identifying a marker chromosome or rearrangements involving acrocentric chromosomes. 
Banding techniques are very efficient in detecting large rearrangements (> 5Mb), but 
smaller chromosomal rearrangements often go unnoticed especially in regions where 
banding pattern is not distinctive. With the advent of molecular cytogenetic techniques it 
has become possible to obtain a higher resolution and to detect rearrangements of smaller 
magnitude. 
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1.5) Molecular cytogenetic techniques 
ISH (In Situ Hybridization) - Joe Gall and Mary Lou Pardue in 1969 used DNA-RNA 
hybridization to localize genes that encode rRNA, this was the first in situ hybridization 
analysis reported (Gall et al., 1969). It was based on complementarity of bases, A with T 
and G with C. Radioisotope labeled probes were hybridized to cell preparations and 
detected using autoradiography. This was followed by the introduction of fluorescently 
labeled antibodies that recognized specific DNA-RNA hybrids (Rudkin et al., 1977). 
1.5.1) FISH (Fluorescent In Situ Hybridization) - Later, chemical coupling of a 
fluorochrome to an RNA probe was used for direct visualization of the target 
(Bauman et al., 1980). Currently, in FISH technique, a fluorescently labelled DNA 
probe is hybridized to cytological targets such as metaphase chromosomes, 
interphase nuclei, fixed tissues, cell smears, or extended chromatin fibers (Fiber-
FISH). Interphase FISH is advantageous in the rapid screening of many nuclei 
without the need for cell culture to get metaphases. FISH can be used both for 
unique and repetitive sequences. It is used to detect and localize the presence or 
absence of specific DNA sequences on chromosomes. On a broader scale, this 
technology can be utilized for the characterization of chromosomal 
rearrangements and marker chromosomes (Blennow et al., 1993; Pinkel et al., 
1988), the detection of microdeletions (Ledbetter 1995) and the prenatal diagnosis 
of common aneuploidies (Klinger et al., 1992; Ward et al., 1993). 
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FISH is a technique that allows DNA sequences to be detected on metaphase 
chromosomes or on interphase nuclei. There are three major categories of DNA 
sequence used as probe for FISH studies. 
1.5.1.1) Satellite sequence Probes - Satellite sequences are polymorphic, 
repetitive DNA sequences that are present in the genome but do not 
code for gene products. Different individuals have variations in the 
number of copies of these DNAs. Locations of such DNA are 
centromeres (alpha-satellite DNA), telomeres (TTAGGG repeats), tip 
of acrocentric chromosomes (P-satellite DNA); and classic satellite I 
DNA found on chromosomes 1,9, 16, and Y. These probes are useful 
in determining the number of specific chromosomes present on 
interphase or metaphase. 
1.5.1.2) Unique sequence Probes - These probes target sequence that are not 
repeated in the genome and may code for genes. They are aimed at 
unique sequences in subtelomeric regions or genes such as c-myc, her-
2-neu, etc and can be used in the identification of microdeletions. 
1.5.1.3) Whole chromosome Paints (WCP) - Whole chromosome probes are 
composed of numerous unique and repetitive sequences, each derived 
from one entire chromosome (Cremer et al., 1988) (Figure 17). These 
probes are designed to use on metaphase chromosomes only. WCPs are 
used to detect subtle or cryptic translocations, insertions or to 
determine the composition of marker chromosomes. 
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Figure 17: Whole chromosome painting on blood metaphase of case 1 on 
chromosome 7, confirming there are no rearrangements. 
Ofilher teetoigiuies 
1.5.2) M-FISH- (Speicher et al , 1996) Using Multiplex-FISH (M-FISH), all the 
24 chromosomes are painted with a different color using probes labeled 
with combinations of multiple fluorochromes. Images are collected with a 
fluorescence microscope that has filter sets for each fluorochrome. It is an 
approach that permits the simultaneous identification and analyses of all 
the chromosomes. 
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1.5.3) SKY- (Schrock et al., 1996) Spectral Karyotyping is an automated 
chromosome painting procedure. The principle is same as M-FISH except 
that an interferometer is used for fluorochrome discrimination and 
imaging. 
1.5.4) Multicolor-Banding- (Chudoba et al., 1999) Multicolor-banding is based 
on differentially labeled overlapping micro dissection libraries. This allows 
the chromosome to have various colored bands. 
1.5.5) Fiber-FISH- (Heng et al., 1992) DNA fibers are released from the 
interphase nucleus on microscope slide and hybridization is done. It offers 
a high-resolution approach for physical mapping and genome research. 
1.5.6) Quantitative-FISH/PNA-FISH- This technique is used to measure telomere 
length. Telomeric PNA (peptide nucleic acid) probes are hybridized to 
normal metaphase spreads and the intensity of the signals is measured 
using software to assess in determining the relative length of the telomeres. 
1.5.7) PRINS (Primed in situ Labeling) was designed by Koch et al (Koch et al., 
1989). This method is based on annealing of specific short oligonucleotide 
primers to the denatured DNA, followed by subsequent primer extension 
using taq DNA polymerase and simultaneous labeling of the target 
sequences with a fluorochrome. However it is specific for repetitive 
sequences only. This technique has been used to detect aneuploidies 
efficiently. 
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1.6) Molecular genetics techniques 
1.6.1) Microsatellite analysis - Parent of origin studies by genotyping can be 
performed using polymorphic markers. The higher the heterozygosity, the 
more informative the marker is i.e. if the parents carry different alleles, the 
origin of each allele in the offspring can be determined accurately. 
Microsatellites are short tandem repeat (STR) markers which are polymorphic 
DNA loci present throughout the genome and contain a repeated nucleotide 
sequence. These loci are amplified using primers by PCR and different sized 
alleles are separated using polyacrylamide gel electrophoresis. Microsatellite 
markers can be used to search for irregular allele inheritance, detection of 
deletions, or uniparental disomies (Ghaffari et al., 1998). 
1.6.2) Comparative Genomic Hybridization (CGH) - Comparative Genomic 
Hybridization was first developed in 1992 (Kallioniemi et al., 1992), to map 
genomic imbalances in solid tumors since preparation of high-quality 
metaphase spreads is difficult in solid tumors. Further, du Manoir et al. (du 
Manoir et al., 1993) used it to detect complete or partial chromosome gains 
and losses. It is now extensively used in clinical and research labs. In this 
technique, DNA is extracted from the test sample and a normal reference 
sample. It is then differentially labeled; traditionally test sample is labeled in 
green and normal reference in red. The combined probes are then co-
hybridized to normal target metaphase chromosomes. If a region is amplified 
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in the test sample the corresponding region on the metaphase chromosome 
becomes green while if a region is deleted it becomes red. The red/green ratio 
is then quantified using digital image analysis. The metaphase chromosomes 
are replaced by mapped clones in case of array-CGH (aCGH) that offers a 
higher resolution screening (Pinkel et al., 1998; Solinas-Toldo et al., 1997). 
The highest resolution for aCGH is now provided by oligonucleotide arrays 
(Carvalho et al., 2004; Lucito et al., 2003; Zhao et al., 2004). 
One of the main advantages of CGH is that it does not require any prior knowledge of 
the chromosome imbalance involved. 
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2. Terminal Deletion of Chromosome 
Exposure to ionizing radiation or other exogenous or endogenous chromosome-
breaking agents during pregnancy can produce double-strand breaks in DNA 
resulting in chromosomal deletion. These can range in size from a few base pairs 
to many megabases in length. 
A chromosomal deletion is usually a sporadic event that occurs in the egg or 
sperm before or after fertilization. The sperm and egg contain 23 chromosomes 
each. After fertilization the chromosome number restores to normal 46 in the 
zygote, each parent contributing one chromosome each (23 in total) out of the 
homologous pair of every chromosome. A deletion may thus cut out important 
genes, which often results in an abnormal genetic condition. Deletions that are not 
inherited from the parents and occur de novo are called as sporadic deletions. In 
other cases it can be inherited, where the parent is a carrier of a chromosomal 
anomaly like a deletion or a translocation. Balanced chromosomal rearrangements 
can generate gametes with genetic imbalance (partial monosomy/trisomy) due to 
aberrant segregation during meiosis. Various chromosomal deletions have been 
reported till date, some of them resulting in deletion syndrome, each syndrome 
characterized by a variety of symptoms. Below are described one common and 
one rare terminal deletion, followed by the 7q terminal deletion, to compare and 
understand the etiology of terminal deletion syndromes. 
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2.1 Terminal Deletion Syndromes 
2.1.1 Monosomy lp36: 
Deletion of chromosome band lp36 or monosomy lp36 has been considered to be 
one of the most common chromosome deletion syndromes, with an estimated 
incidence of 1 in 5,000 to 1 in 10,000 live births (Heilstedt et al., 2003). This 
syndrome was first reported in 1980 and occurs due to the partial loss of material 
from the short arm of chromosome 1. The breakpoints range from bands lp36.13 
to lp36.33 in this cytogenetic syndrome. The majority of cases reported in the 
literature are with pure terminal deletions. The clinical symptoms include-
developmental delay, mental retardation, brain abnormalities, heart abnormalities, 
characteristic craniofacial appearance, deep-set eyes, midface hypoplasia, broad 
nasal root/bridge, long philtrum, and pointed chin. This syndrome is responsible 
for -1% of all cases labeled as "idiopathic mental retardation" (Giraudeau et al., 
2001). Other features observed were microbrachycephaly, epicanthal folds, 
posteriorly rotated malformed ears, seizures, hearing impairment, microcephaly 
etc (Battaglia et al., 2008). Individuals with lp36 syndrome often face serious 
physical disabilities. This syndrome includes a wide range of symptoms variable 
in nature. 
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2.1.2 14q terminal deletion: 
Terminal deletions of chromosome 14 (14q32) are quite rare. This deletion leads 
to 14q terminal deletion syndrome. About 20 such patients have been described in 
the literature. The most common clinical manifestations are- microcephaly, broad 
nasal bridge, high forehead with lateral hypertrichosis, long and broad philtrum, 
high arched palate, epicanthic folds, single palmar crease, hypotonia, mental 
retardation and developmental delay (Schlade-Bartusiak et al., 2009). This 
syndrome in not generally associated with multiple congenital anomalies. The 
symptoms in these patients are sufficiently specific to allow delineation of a 
clinically recognizable syndrome (van Karnebeek et al., 2002). 
2.1.3 7q terminal deletion: 
More than 100 cases of 7q terminal deletion have been described in the literature. 
The first such case was described by De Grouchy and colleagues (De Grouchy et 
al., 1968), which was initially thought to be a case of 6p deletion instead. The term 
"7q deletion syndrome" was coined by Harris and colleagues (Harris et al., 1977) 
when they described four cases carrying terminal deletion 7q32 with the following 
clinical manifestations - growth deficiency, developmental delay, prominent 
forehead, bulbous nasal tip, abnormally shaped ears, cleft lip and palate, genital 
abnormalities and simian creases. Since then, many other clinical features have 
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been associated with 7q terminal deletion patients, such as holoprosencephaly 
(HPE), sacral agenesis, mental retardation, feeding difficulties and hearing 
problems. Some of the symptoms described above are common to other 
chromosomal imbalances while others are specific to 7q deletion. A review of the 
cases described before reveals that the patients carrying an apparently similar 
deletion, for example 7q36, present variable phenotypes. This tendency was also 
observed in the three patients we studied. Also, the severity of holoprosencephaly, 
a common developmental defect of the forebrain, varies widely in different 
carriers (Roessler et al., 1996). Thus, it becomes essential to characterize the 
deletion, to locate the exact breakpoint, to study the genes involved and to 
evaluate the cause of such phenotypic variability. Possibility of role of modifier 
genes, polymorphism and/or position effect is discussed. 
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Interest of our study 
Chromosomal anomalies contribute to a significant number of miscarriages or induced 
abortions. Those anomalies that are compatible with life usually result in mental 
retardation, growth retardation and other malformations in the fetus/infant. Consequently, 
it is important to investigate chromosomal aberrations that are compatible with post-natal 
life but intervene with the normal development of the embryo. This gives a better 
understanding of the anomaly so that a better diagnosis and care can be provided. It is 
further interesting to analyze why certain anomalies present heterogeneous phenotypes. 
We studied three patients who carried 7q terminal deletion, all with variable symptoms. 
With the recent advancement in cytogenetic techniques it has become possible to 
characterize such deletions at a very high-resolution. Using these tools we localized the 
deletions, stratified the symptoms associated with 7q35 and 7q36 terminal deletions, 
established a genotype-phenotype correlation along with the literature review of similar 
cases. 
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Objectives 
• Collect the clinical information of the three patients. 
• Identify the chromosomal anomaly in these patients using conventional 
cytogenetic techniques, such as low- and high-resolution karyotype, followed by 
performing the same techniques in the parents to determine whether the anomaly 
has been transmitted or has occurred de novo. 
• Establish whether the deletion is interstitial or terminal using subtelomeric FISH 
on chromosome 7. 
• Search for mosaicism (case 1), by performing subtelomeric FISH on chromosome 
7 on cells from skin (fibroblasts) and buccal smear (epithelial cells). 
• Determine whether the chromosome that carries the deletion is maternally or 
paternally derived using microsatellite analysis and locate the exact breakpoint. 
• To look for cryptic aberrations using very high-resolution array-CGH, determine 
the precise length of the deleted segment and the genes lost. 
• Confirm the result of array-CGH (Xq28 duplication) for case 3, using 
subtelomeric and centromeric FISH on chromosome 7 and X. 
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• Review the literature with cases carrying 7q terminal deletion and other 
chromosomal terminal deletions and observe the clinical symptoms that these 
cases manifested. 
• Establish a genotype-phenotype correlation based upon the published data and our 
three cases and stratify the symptoms associated with these deletions. 
• Finally, speculate why patients with similar 7q terminal deletion present variable 
phenotypes. 
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Resume (de Particle) 
Introduction- La monosomie partielle du bras long du chromosome 7 est associee a un 
large spectre de manifestations cliniques, notamment l'holoprosencephalie et l'absence de 
sacrum. Cependant, il reste a definir une relation claire entre le genotype et le phenotype 
dans les differents cas du syndrome de deletion 7q. 
Objectifs- Caracteriser trois cas cliniques possedant tous une deletion du bras long du 
chromosome 7 mais presentant des phenotypes cliniques differents. 
Materiels et methodes- Les caryotypes des trois patients ont ete realises en utilisant la 
methode de marquage GTG de base ainsi qu'a haute resolution. L'etude par hybridation 
in situ en fluorescence de sondes subtelomeriques et l'analyse des microsatellites a l'aide 
de differents marqueurs specifiques du chromosome 7 ont ete effectuees. Nous avons 
egalement realise une exploration par micropuce sur ces trois cas. 
Resultats- Le ler patient portait une deletion de novo de 6.6 Mb au niveau de la bande 
7q36.2 du chromosome 7 herite de la mere. Le point de cassure de cette deletion etait 
situee entre les marqueurs D7S483 et D7S798. Cet enfant a comme unique anomalie 
phenotypique une agenesie partielle de sacrum. Le 2e cas etait porteur d'une deletion 
terminale de novo de 13.8 Mb localisee a la bande 7q35 du chromosome 7 herite du pere. 
Le point de cassure de cette deletion etait localisee entre les marqueurs D7S661 et 
D7S2426. A l'autopsie, ce foetus presentait une pyelectasie du rein droit avec une 
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hypertrophic pelvienne. Le 3e patient est porteur d'une deletion terminale de novo de 7.2 
Mb au niveau de la bande 7q36.1 et d'une duplication de 1.2 Mb localisee a la bande 
Xq28. A l'exception d'une microcephalic notee a la naissance, ce dernier cas n'avait 
aucun signe phenotypique anormal. Le point de cassure de cette deletion etait localisee 
entre D7S642 et D7S483. II est a noter que ces deux derniers cas ne presentaient ni HPE, 
ni agenesie du sacrum. 
Conclusion- Les cas presentes ici soulignent 1'importance et le role des facteurs 
environnementaux, des genes modificateurs et/ou de l'effet de position sur les differents 
phenotypes observes dans le cas de deletion 7q. 
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Three New Gases of Terminal Deletion of the Long Arm of 
Chromosome 7 and Literature Review to Correlate Genotype and 
Phenotype Manifestations 
AYUB Seemi1, GADJI Macoura1, KRABCHI Kada1, COTE Sylvie2, GEKAS 
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Short title: Terminal deletion of the long arm of chromosome 7. 
ABSTRACT 
Introduction- Partial monosomy of the long arm of chromosome 7 (7q) has been characterized 
by wide phenotypic manifestations, but holoprosencephaly (HPE) and sacral agenesis have 
always been associated with this chromosomal deletion. A clear relationship between genotype 
and phenotype remains to be defined in the 7q deletion syndrome. 
Objective- To investigate three patients with a 7q terminal deletion presenting variable 
phenotypes and compare with similar deletion cases in the literature to stratify the phenotypes 
associated with 7q35 and 7q36 terminal deletion patients in context of 7q deletion syndrome. 
Materials and Methods- G-banding was carried out at low and high-resolution. Fluorescent In 
Situ Hybridization (FISH) using sub-telomeric probes was performed followed by microsatellite 
analysis using markers specific for chromosome 7. Finally, a whole genome microarray analysis 
was also performed. 
Results- Patient 1 was carrying a de novo terminal deletion at band 7q36.2 on the maternally 
derived chromosome, located between the markers D7S483 and D7S798. Patient 2 was carrying 
a de novo terminal deletion at band 7q35 on the paternally derived chromosome, located between 
the markers D7S661 and D7S2426. Patient 3 had a de novo terminal deletion at band 7q36.1 on 
the paternally derived chromosome, located between the markers D7S642 and D7S483. A small 
Xq28 duplication was also identified by array-CGH, which was missed by a standard karyotype. 
Patient 1 presented partial sacral agenesis. However neither HPE nor sacral malformations were 
observed in patients 2 & 3. 
Conclusion- Our patients with terminal 7q deletion presented heterogeneous phenotypic 
manifestations which highlights the significance and role of environmental factors, modifier 
genes and/or polymorphism. Growth retardation was the most frequent symptom found in both 
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7q35 and 7q36 patients. The presence of HPE and sacral malformation together was seen in less 
than 10% of the cases in both kinds of deletion. HPE was mostly related to the cases with an 
unbalanced translocation. 
INTRODUCTION 
7q deletion is a rare chromosomal structural aberration, which involves the loss of the terminal 
region of the long arm of chromosome 7. The first case of a 7q deletion was described in 1968 
(De Grouchy et al., 1968). The carriers of this deletion present a wide variety of symptoms while 
sharing a few common features. The main clinical features associated with it are - growth and 
motor retardation, mental retardation, hypotelorism, hypotonia, microcephaly, upslanting 
palpebral fissures, prominent forehead, epicanthal folds, cleft lip, flat and broad nasal bridge, 
bulbous nasal tip, micrognathia, abnormal palmar crease, feeding problems, and low set ears 
among others, described as 7q deletion syndrome in 1977 (Harris et al., 1977) and reviewed in 
2005 (Lukusa et al., 2005). However, despite several decades of research trying to decipher the 
molecular mechanisms of the symptoms in 7q deletion syndrome, until now a clear relationship 
between genotype and phenotype remains to be defined. 
Furthermore, 7q terminal deletion has been time and again linked with sacral agenesis 
(Nowaczyk et al., 2000; Wang et al., 1999) and midline embryonic field defects like 
holoprosencephaly (HPE), which can range from cyclopia to a single central upper inscisor 
(Roessler et al., 1996). HPE is generated by common and complex malformations affecting the 
cleavage of the developing forebrain and is accompanied with defects in the mid face 
(Benzacken et al., 1997). It is divided in three types: alobar, semilobar and lobar HPE and occurs 
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in 1/16,000 live births and in 1/250 spontaneous abortions (Kanafani et al., 2007. The gene SHH 
present on 7q36 on loci HPE3 was identified to be one of the genes to cause HPE {Belloni, 1996 
#2; Roessler et al., 1997a; Schell-Apacik et al., 2003). Genetically, chromosomal aberrations 
such as triploidies, trisomies 13 or 18, mendelian inheritance or rearrangements of at least those 
12 gene loci located on 11 different chromosomes are implicated in the pathogenesis of HPE 
(Kanafani et al., 2007), (Roessler et al., 1998). Also, this clinical feature is frequently associated 
with sacral agenesis in 7q36 deletion. Sacral agenesis also ranges from partial agenesis of the 
coccyx to complete absence of the sacral, lumbar and seldom thoracic vertebrae (Pang 1993). 
Currarino syndrome occurrence is 1.3/10,000 live born and it consist of the triad of anorectal 
malformation, a sacrococcygeal defect, and a presacral mass, recognized as a syndrome in 1981 
(Currarino et al., 1981). In addition, HLXB9 was identified as the major gene causing sacral 
agenesis also residing on 7q36 (Ross et al., 1998). HLXB9 misense mutations and deletions have 
been identified in some Currarino's syndrome (Belloni et al., 2000). 
However, deletion of these genes does not necessarily imply a severe phenotype. The severity of 
symptoms varies between individuals carrying an apparently cytogenetically similar deletion 
(Frints et al., 1998; Lukusa et al., 2005). Most of the patients described before have been 
evaluated using standard cytogenetic techniques (G or R banding), which gives a relatively low-
resolution localization of the breakpoint limited to the band level. Here we report a detailed 
cytogenetic and molecular investigation of three patients carrying a 7q deletion. We performed 
microsatellite analysis and array-CGH to precisely define the breakpoint, to study the genes lost 
and to investigate the symptoms usually associated with 7q deletion syndrome. We stratified the 
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symptoms manifested by 7q35 and 7q36 deletion patients and investigated the most common 
phenotypes and their percentage (based on a total of 55 cases). 
CLINICAL REPORTS 
Patient 1 
The girl was born to 23-year old parents and is now 9 years old. At birth her height was 45 cm, 
weight was 2.5 kg and a cranial perimeter of 30.5 cm was observed. She walked at 16 months. A 
neurologic examination revealed axial hypotonia. She spoke at three and a half years and also 
suffered moderate hearing problems. The following clinical symptoms were observed: 
microcephaly, psychomotor retardation, webbed shortened neck, multiple nevi on different areas 
of the body, marble-like pattern on the skin of the whole body similar to fishnet-like blotches, 
small bilateral cubitus valgus, broad chest with shield-like thorax, widely spaced nipples, 
congenital partial sacral agenesis and skeletal deformity inducing to a lumbar congenital 
hyperlordosis. There were slight cranio-facial dysmorphism signs such as oval face shape, large 
forehead, small eyes, bilateral and symmetric well-shaped ears normally implanted, eumorphic 
macrotia with salient antihelix and big antitragus. At the exam of the oral cavity and palate, we 
noted thin lips, hypoplastic orbicularis oris muscle leading to undergrowing median area of lower 
lip, malocclusion of teeth, slightly large palate, but globally, the central segment of the face, 
comprising the forehead, supraorbital ridges, nose, philtrum, and primary palate, which derived 
from the frontonasal process, was close to normal; buccal cavity was otherwise normal. She is at 
the Tanner stage II characterized by isolated premature thelarche II (breast buds are formed and 
palpable, with small area of surrounding glandular tissue; areola begins to enlarge), pubarche I 
(no pubic hair at all) corresponding to the prepubertal stage, no menarche and no premature 
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adrenarche. MRI of the brain revealed complete corpus callosum. The mother suffered from 
pyelonephritis and was on antibiotics for the same during 12-13 weeks of the pregnancy. The 
father had hearing problems in one ear due to fused bones. 
Patient 2 
An amniocentesis has been performed for high risk of trisomy 21 at the prenatal serum marker 
screening test. A 7q deletion was detected and the parents decided to interrupt the pregnancy. 
This is a male fetus that was aborted at 22 weeks. The mother was 32 years old and the 
pregnancy was normal. Fetal ultrasound showed an occipitofrontal circumference at the 5th 
percentile. An autopsy determined the weight to be 390.6 g, height 25 cm, head circumference 
18 cm (5th percentile), and circumference of thorax 16.5 cm. There was no facial dysmorphism, 
nasal and buccal cavities were well configured. There was a right kidney pyelectasia with no 
kidney dysplasia. Thorax, abdomen and back were without any particularity. The respiratory, 
cardiovascular, gastrointestinal, endocrine and hemolymphatic system were normal. There were 
no signs of HPE on examination of the nervous system. The cerebral hemispheres were 
symmetric and the ventricles were not dilated. 
Patient 3 
This is a 2 years and 8 months old girl. At the time of examination, her weight was 10.2 kg, 
height was 84 cm and cranial perimeter was 43 cm, all below the 3rd percentile. She had 
microcephaly since birth. Development was acceptable in the first six months but slowed down 
later in life. She never developed any language and has difficulties walking. Hearing and vision 
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were normal. MRI of the brain was found to be normal. Dentition is normal. Thus, she had no 
signs of HPE. An X-Ray of the pelvic region ruled out any sacral malformations. 
MATERIALS AND METHODS 
Conventional Cytogenetics 
Sampling 
After genetic counseling, 5 to 10 ml of peripheral venous blood was collected in a vacutainer 
sodium heparin tube (Becton Dickinson Vacutainer Systems, Franklin Lakes, NJ) from the 
proband, mother and father. Skin biopsy and buccal smear from the patient 1 was taken and 
suspended in complete medium (RPM1, DMEM, 10% FBS, 2% antibiotics) and HBSS (Hank's 
balanced salt solution) respectively. Approximately 20 ml of amniotic fluid was obtained 
through the usual procedure from patient 2. 
Low resolution karyotype 
Blood (0.5 ml) was taken in Falcon polypropylene tubes (15 ml) for each sample with 10 ml of 
culture medium (88% RPM1, 10% FBS, 1% glutamine, 1% PHA, 0.01% antibiotics). The blood 
culture was incubated at 37°C, 5% C02 (MCO-20 AIC, Sanyo electric Biomedical Co., Ltd, 
Japan). After 3 days, 50 |il of colcemide (10 (ig/ml) was added for 1 h before harvest. For 
harvesting the tubes were centrifuged at 1500 rpm (c. 500 g, ICE centrifuge, HNSII model A 
Division of Damon, USA) for 7 min and the platelet-rich supernatant was discarded. The cells 
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were resuspended in a hypotonic solution (0.56% KC1) and incubated at 37°C for 10-15 min. 
After cytocentrifugation for 5 min at 2000 rpm (c. 667 g), the cells were fixed several times with 
freshly prepared precooled Carnoy's fixative (3:1, methanol: glacial acetic acid). The pellet was 
resuspended in 1 ml of fresh Carnoy. We spread 15 fil of fixed cell suspension onto cleaned 
slides in a modified Thermotron environmental control unit (CDS-5, Thermotron, Amsterdam, 
Holland) at an optimal temperature (22°C) and humidity (55%). The slides were aged for a few 
days and GTG (G-bands by trypsin using Giemsa) was performed according to the standard 
protocol (Drouin et al., 1988). 
High-resolution karyotype 
Blood was cultured as described above, but after 3 days in incubation, the cells were blocked 
with thymidine (300 |ag/ml final) and were incubated again. After 17 h, tubes were centrifuged at 
1700 rpm for 7 min. The pellet was washed with HBSS. Cells were centrifuged again and 10 ml 
of release medium was added followed by 0.5 ml of BrdU (5-bromo-2'-deoxyuridine) to a final 
concentration of 30 (ig/ml. Incubation was done for 4 h 45 min. Colcemide was added 50 |_il in 
each tube as above. This was incubated at 37°C in water bath for 15 min. Rest of the protocol 
was same for harvest and G-banding (Drouin et al. 1988). 
Fifteen metaphases were counted and 5 metaphases were karyotyped. 
Amniotic fluid culture 
Amniotic culture from patient 2 was done following the standard protocol (Barch et al., 1997). 
Fibroblast culture 
Skin biopsy was cultured in the medium according to standard method to obtain fibroblast and 
fibroblastic metaphases. After the cells became confluent, they were harvested using standard 
protocol (Barch et al., 1997). 
Buccal smear 
Buccal smear was harvested using the same protocol as blood. The hypotonic shock was given in 
sodium citrate (0.4 %) for 20 min. 
Molecular cytogenetics 
Harvested sample was spread on clean slides under optimal conditions and incubated at 37°C 
overnight. FISH using sub-telomere probes for chromosome 7 in all patients was performed 
(Abbott Molecular Inc., Downers Grove, IL, USA). FISH was done on chromosome X in patient 
3 after array results. We also performed Whole chromosome Painting (WCP 7, Abbott Molecular 
Inc., Downers Grove, IL, USA) on chromosome 7 in patient 1. Sub-telomere FISH on fibroblasts 
and buccal smear cells was done using same probes on chromosome 7. Before FISH, pre-
treatment was done on buccal smear slides in 2xSSC for 30 min, digestion solution (50 ml water, 
500 fa.1 IN HC1, 2.5 |al 10% pepsin) for 12 min at 37°C, IX PBS 5 min, formaline (1 ml 
formaldehyde 37%, 800 Mgcl2 2.5M) 5 min, IX PBS 5 min, followed by dehydration in 70%, 
80% and 100% ethanol for 2 min each. 
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All slides were examined under Olympus BX61 microscopes equipped with appropriate filters at 
1000X magnification. Imaging of selected cells was done using JAI M300 video CCD camera. 
The pictures were analyzed using the in situ imaging system (ISIS) software version 5.2 
(MetaSystems Inc, Belmont, MA). 
Fifty metaphases were examined for buccal smear and fibroblasts. Ten metaphases were counted 
for sub-telomeric FISH. 
Molecular Genetics 
Microsatellite analysis 
To determine the exact breakpoint on a physical map and the parental origin of the deleted 
chromosome, microsatellite analyses were carried out with many flanking 
oligodeoxyribonucleotides as primers that map the chromosome 7. The DNA from mother, father 
and proband was extracted using QIAGEN Kit (QIAGEN Sciences, Maryland 20874, USA) and 
was typed with a series of polymorphic (CA)n microsatellite repeats. The microsatellite markers 
tested for the 3 patients are shown in table 1. The PCR was performed using 10 to 30 ng of 
genomic DNA, 2.5 mM of dNTPs (Roche), 1 |iM of the forward and reverse primers. The 
forward primer was labeled with IRD700 (M13IRD700) (Li-Cor, Lincoln, NE, USA) for direct 
detection. The amplification reaction (Biometra, Montreal Biotech Inc thermocycler, Kirkland, 
Quebec, Canada) contained Hot Start Taq (5 U/|al) (Qiagen) was cycled for 35 cycles after 
preheating at 95°C for 15 min: 1) denaturation at 95°C for 40 s; 2) annealing at 55°C for 30 s; 3) 
extension at 72°C for 40 s. The amplified products were resolved on 6% polyacrylamide gel 
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using the Li-Cor Sequencer (NEN 4300L DNA analyzer, LI-COR Inc. Lincoln, NE) according to 
the manufacturer's protocol. 
Array CGH 
DNA from the mother, father and patient was extracted as mentioned above and array CGH was 
performed by Gene Dx (Perry Parkway, Gaithersburg, MD) using GenomeDx microarray, v3.0. 
The patient's DNA was labeled with red fluorescent dye and control DNA with green fluorescent 
dye. This was combined in equal ratio and hybridized to a glass slide coated with probes for 
whole genome. The array contained approximately 105,000 oligonucleotide probes spaced at an 
average distance of 37 kb (http://genome.ucsc.edu/cgi-bin/hgGatewav). After hybridization the 
ratio of red to green was determined using analysis instrument. 
RESULTS 
Conventional cytogenetics 
Low-resolution karyotype- In patient 1, both chromosomes appeared normal. A terminal deletion 
on the long arm of one of the chromosomes 7 was observed in patients 2 and 3 (Figure lai, lb 
and lc). The karyotype of the parents was normal in all the three patients. 
High-resolution karyotype- Terminal deletion on the long arm of chromosome 7 was observed 
(patient 1) (Figure la2). 
Patient 1- 46,XX,del(7)(q36) 
Patient 2- 46,XY,del(7)(q3?5) 
Patient 3- 46,XX,del(7)(q3?5) 
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Molecular cytogenetics 
Only one red signal at 7p confirmed 7q terminal deletion in patient 1 (2a), patient 2 (2b) and 
patient 3 (2c). In patient 1, whole chromosome painting confirmed that there were no re-
arrangements. Sub-telomeric FISH on buccal smear and fibroblasts confirmed that there was no 
mosaicism (Figure 18). An Xq duplication was later confirmed in patient 3 after array analysis 
(2d). 
Patient 1- ish del(7)(qter-)(VIJyRM2000-) 
Patient 2- ish del(7)(qter-)(VIJyRM2000-) 
Patient 3- ish del(7)(qter-)(VIJyRM2000-) and ish der(7)t(X;7)(qter+,qter-) after array-CGH 
Microsatellite analysis 
Patient 1- The deletion was located between the markers D7S483 and D7S798 on maternally 
derived chromosome between bands 7q36.1 and 7q36.2. Shown in figure 3 is a deleted and a 
normal marker (Figure 3a and 3d). 
Patient 2- The deletion was located between the markers D7S661 and D7S2426 on paternally 
derived chromosome between bands 7q35 and 7q36.1. Shown in figure 3 is a deleted and a 
normal marker (Figure 3b and 3e). 
Patient 3- The deletion lies between the markers D7S642 and D7S483 at band 7q36.1 on 
paternally derived chromosome. Shown in figure 3 is a deleted and a normal marker (Figure 3c 
and 3f). 
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Array CGH 
Patient 1- The deletion was located at chromosome region 7q36.2q36.3 from genomic position 
152,213,519 to 158,818,165 bp. The estimated size of this genomic imbalance is 6.6 Mb. (Figure 
4a). This deletion results in the loss of one copy of approximately 30 genes, which include 
OMIM genes SHH (OMIM#600725), HLXB9 (OMIM# 142994), LMBR1 (C)MIM#605522), and 
EN2 (OMIM#131310) (from UCSC OMIM gene track). 
Patient 2- The deletion was located at chromosome region 7q35q36.3 from genomic position 
144,999,574 to 158,818,166 bp. The estimated size of this genomic imbalance is 13.8 Mb. 
(Figure 4b). This deletion results in the loss of one copy of approximately 65 genes, which 
include OMIM genes SHH (OMIM#600725), HLXB9 (OMIM#142994), LMBR1 
(OMIM#605522), and EN2 (OMIM#131310). 
Patient 3- The deletion was located at chromosome region 7q36.1q36.3 from genomic position 
151,623,385 to 158,818,166 bp. The estimated size of this genomic imbalance is 7.2 Mb. (Figure 
4c). This deletion results in the loss of one copy of approximately 35 genes, which include 
OMIM genes SHH (OMIM#600725), HLXB9 (OMIM# 142994), LMBR1 (OMIM#605522), and 
EN2 (OMIM#131310). In addition, a 1.2 Mb duplication was present at chromosome region 
Xq28q28 from genomic position 153,665,271 to 154,883,307 containing approximately 11 genes 
(Figure 4d). 
Parental samples yielded normal results. 
The cytogenetic formulas for the 3 patients are-
Patient 1- 46,XX,del(7)(q36.2) 
Patient 2- 46,XY,del(7)(q35) 
Patient 3- 46,XX,der(7)t(X;7)(q28;q36.1) 
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DISCUSSION 
Several patients with 7q deletion have been described in the medical literature without 
characterizing the "exact" breakpoint and the role of the genes lost in the occurrence of the 
symptoms. This limitation has been mostly related to the low-resolution of cytogenetic tools 
used. We performed microsatellite analysis and array-CGH in order to overcome this limitation. 
The resolution limit has increased from 2-5 Mb to 0.3-0.5 Mb with the advent of these 
techniques. 
The deletion 7q36.2, which we present in patient 1 is very small and rare, since most of the 
deletions that have been characterized until now were located either at 7q32, 7q35 or 7q36.1. To 
our knowledge this is the first case reported with 7q36.2 deletion, probably due to the limited 
cytogenetic tools available in the past. This patient (patient 1) presented with partial sacral 
agenesis that could be explained due to loss of the gene HLXB9 present on band 7q36.3. 
According to the microsatellite and microarray results the gene SHH is also deleted in this 
patient. However she did not show any severe forms of HPE, but only had microcephaly which is 
considered to be the mildest expression of HPE by some authors. To explain her phenotype, we 
determined whether she carried mosaicism by doing sub-telomere FISH specific for chromosome 
7 on fibroblasts and buccal smear cells. All tissue cells examined had a del(7qter) . The results 
reduced the possibility of the patient carrying two kinds of cell population, one normal and one 
abnormal that could have explained her phenotype. 
The deletion in patient 2 (fetus) included the SHH and HLXB9 genes, however, he neither 
presented HPE nor sacral dysgenesis. Even though it was a 22 weeks old fetus that was 
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terminated, it could be assumed that no other symptoms would develop later in the following 
weeks. Nevertheless regarding the literature with fetuses carrying a 7q terminal deletion reveals 
that some of them presented severe forms of HPE (alobar HPE/cyclopia) (Burrig et al., 1989; 
Chen et al., 1999; Kurtzman et al., 1987). However, these were the cases that carried an 
unbalanced translocation and the fetus that we report here had a pure terminal deletion. 
Patient 3 carried a 7q36.1 deletion along with the duplication of Xq28. Xq28 duplication is 
known to cause developmental delay, distinctive facial features, major axial hypotonia, severe 
feeding difficulties, abnormal genitalia and susceptibility to infections (Sanlaville et al., 2005). 
Like other two patients, she did not present with HPE and sacral agenesis. It is apparent that the 
deletion of 7q and the genes SHH and HLXB9, did not have any severe effects on the phenotype 
in patients 2 and 3, even though it was a larger deletion than in patient 1. Other symptoms like 
microcephaly, growth and mental retardation, hypotonia, hypotelorism, urogenital anomalies are 
common to most of the chromosomal deletions (Evers et al., 1996; Hiraki et al., 2008; Scigliano 
et al., 2004; Telford et al., 1990) signifying the requirement and role of many genes present on 
different chromosomes in the normal development of the human brain. 
We have discussed our three new patients (two 7q36 (m, o) + one 7q35 (n)) and twelve previous 
cases (ten 7q36 + two 7q35) from the literature that were not included in the review by Lukusa et 
al. (Lukusa et al., 2005) (table 2). The cases from table 2, 30 previous cases with 7q36 deletion 
and 10 cases with 7q35 deletion reviewed in 2005 (Lukusa et al., 2005) were combined in figure 
5. In total there were forty-two 7q36 and thirteen 7q35 deletion cases. By summarizing the 
symptoms presented by these patients it was observed that growth retardation, microcephaly, 
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sacral malformation, HPE, large malformed ears, cleft lip and palate were the most common 
among them. Other symptoms that were observed in a few patients were- psychomotor delay, 
feeding problems, hypotonia, hypotelorism, downslanting palpebral fissures, midfacial 
hypoplasia, micrognathia, depressed nasal bridge, recurrent urinary tract infection, single central 
maxillary incisor etc. 
While sacral malformations were common to cases with both pure terminal deletions and 
unbalanced translocations (A, B), HPE was mostly present only in cases with unbalanced 
translocations (Figure 5). Out of the 13 cases that presented with HPE only one case had a pure 
terminal deletion (C, D). Even though patient 3 had an unbalanced translocation, this pattern was 
not observed in her probably due to the small length of the duplicated segment Xq28, rendering 
it inconsequential. Furthermore, both HPE and sacral agenesis together were found in only four 
cases out of the 55 reported. Of these four cases, three were with unbalanced translocation and 
one with pure terminal deletion (E and F). This implies that unbalanced translocations can 
manifest into more severe phenotypes. In such patients, for example patients b, c, i and k (table 
2), the over expression of a gene due to partial trisomy of the chromosome involved could be the 
cause of variable phenotypes. However in cases of pure 7q terminal deletions, there can be many 
reasons of such variable phenotypes. 
All of our three cases carried different lengths of deletion. In patient 1, the array results 
demonstrated that the deletion was rather terminal localized to 7q36.2. It is possible that the 
patient did not present any severe signs of HPE since this was not an "extensive" deletion. But 
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the patients 2 and 3 carried a more "extensive" deletion than patient 1, which would mean a more 
severe phenotype. However this was not the case, and only the patient with the smallest deletion 
expressed sacral agenesis (patient 1). As a result, the possibility of the extent of deleted segment 
related to the phenotype can be excluded, at least for these three cases. 
Various mechanisms and hypothesis can be used to explain the heterogeneous symptoms. 
It is unlikely that one single mechanism is accountable for phenotypic variations in all cases of 
7q terminal deletion. 
One hypothesis is the role of modifier genes as described in case of cystic fibrosis (CF) (Davies 
et al., 2005), where the severity of CF can vary in siblings carrying a similar mutation in the 
CFTR gene. All of our patients had microcephaly, which can be considered a minimal HPE 
manifestation. It can be assumed that some genetic modifiers of the gene SHH regulate its 
expressivity level through feedback mechanism and modify the product transcripted from the 
intact gene, in case of its deficiency. 
Polymorphism(s) in the coding region of DNA has the ability to affect the response to drugs and 
to influence the severity of a disease. It is possible that protein deficiency resulting due to the 
deletion was compensated by the genes present on the other homologous chromosome, which in 
turn is determined by polymorphism. It appears that polymorphism plays a crucial role in 
patients manifesting different phenotypes in different individuals. It would also explain the 
familial inheritance of HPE or sacral agenesis. Polymorphism in the genetic modifiers of the 
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genes HLXB9 or SHH might also be one of the causes. For example in our study, patients 2 and 3 
did not present with sacral malformation while patient 1 did. Perhaps there was some kind of 
polymorphism present in the intact gene HLXB9 of the other normal chromosome 7 which 
regulated efficiently the gene product in these two patients. 
Another mechanism to explain variability of symptoms is "multiple hit hypothesis" proposed by 
Ming et al. (Ming et al., 2002). According to this hypothesis there are many factors besides a 
single gene, which can control the expression of certain phenotypes, like some genetic factors or 
environmental conditions. It is difficult to accurately determine these factors since their effects 
can take place at any stage beginning from the formation of gametes. 
The presence of severe forms of HPE with or without sacral agenesis has been attributed to 
position effect in cases of balanced translocation involving chromosome 7 (Bedell et al., 1996; 
Fernandez et al., 2005; Kleinjan et al., 2005; Kleinjan et al., 1998). It has been proposed that a 
rearrangement like a balanced translocation may juxtapose a gene with an enhancer element 
from another gene leading to inappropriate gene expression. In other instances, a gene(s), 
through a translocation is placed in a heterochromatic region thereby inhibiting the expression of 
the gene. For example, even though patient d (table 2) with a balanced translocation presented 
with mild form of HPE and no sacral agenesis, she suffered from other severe symptoms due to 
two position effects (Fernandez et al., 2005). 
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CONCLUSION 
Our work gives for the first time a very high-resolution characterization of 7q terminal deletion. 
An important observation that we made was that HPE was mostly found in unbalanced 
translocation cases. Thus, we can conclude that when a 7q terminal deletion is accompanied with 
a partial trisomy of some other chromosome it results in more severe malformation of the brain. 
This can be attributed to extra dosage of genes. HPE in association with sacral malformation was 
present only in ~7% of the total cases studied (table 3). Consequently, a combination of these 
two manifestations together is very rare, irrespective of the kind of rearrangement (pure deletion 
or unbalanced translocation) and/or the band deleted (7q36 or 7q35). 
We propose that haploinsufficiency of the deleted genes were compensated by the product of the 
genes present on the intact homologue resulting in variable phenotypes. Whether it is 
compensated or not can be attributed to varying genetic makeup (polymorphism) in different 
individuals thus resulting in different phenotypes. 
Therefore, we also assume that it is not just one gene which is responsible for a particular 
phenotype like HPE or sacral malformations but various other genes, familial factors and 
environmental factors play a role too. Thus, it appears like it is a "combined effect" rather than a 
single-gene effect. 
Array-CGH enabled us to determine the genes lost. In future, it would be interesting to perform 
array-expression and study the proteins expressed in different patients that would help 
understand the wide range of phenotypes in these deletion carriers. 
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Table 1: Microsatellite markers for the three patients. 
Markers Position Patient 1 Patient 2 Patient 3 
D7S2474 7p22.3 np sp sm 
D7S2559 7p21.1 sp ni ni 
D7S2251 7pl4.2 + + ni 
D7S691 7pl4.1 sp + + 
D7S527 7q21.3 + sp ni 
D7S515 7q22.1 ni ni na 
D7S640 7q32.3 na + + 
D7S2452 7q33 sp sm ni 
D7S2540 7q34 np + np 
D7S661 7q35 + + ni 
D7S2511 7q35 + ni ni 
D7S688 7q36.1 np np + 
D7S2426 7q36.1 + ni 
D7S636 7q36.1 + - ni 
D7S642 7q36.1 np np + 
D7S2439 7q36.1 np np ni 
D7S483 7q36.1 + - -
D7S798 7q36.2 - - -
D7S2462 7q36.2 ni ni -
D7S2546 7q36.2 - - ni 
D7S2447 7q36.2 - ni ni 
D7S550 7q36.3 ni ni -
D7S3037 7q36.3 ni np -
D7S2465 7q36.3 - ni -
D7S559 7q36.3 - ni ni 
D7S2423 7q36.3 - np -
np- not performed, na- not amplified, ni- non informative, sm- semi-maternal, 
sp- semi-paternal, + present, - deleted 
Table 2: Details of the 7q36 and 7q35 patients not reviewed by Lukusa et al, and 
our three new patients. 
Patient 
ID 
Reference Band Inheritance 
pattern 
HPE Sacral 
agenesis 
a (Su et al., 
2008) 
46,XX,del(7)(q3 6) de novo no sacral agenesis 
b (Ginocchio 
et al., 2008) 
46,XY,der(7)t(3 ;7)(p26.3 ;q3 6.1) maternal no no 
c (Kanafani 
et al., 2007) 
46,XY,t(7;8)(q31.3;ql2).ish,del(7)(q36), 
inv(7)(q31.3 q3 ?6)der(8)t(7 ;8)(q31.3;ql2) 
de novo semilobar 
HPE 
no 
d (Fernandez 
et al., 2005) 
46,XX,t(6;7)(p21.1 ;q36) de novo Mild 
form 
no 
e (Horn et 
al., 2004) 
(patient 1) 
46, XY, del(7)(q36.3) de novo no Partial sacral 
agenesis 
f (Horn et 
al., 2004) 
Patient 2 
46, XY, del(7)(q36.3) de novo no no 
g (Horn et 
al., 2004) 
Patient 3 
46, XY, del(7)(q36.3) de novo no no 
h (Horn et 
al., 2004) 
Patient 4 
46, XY, del(7)(q36.3) de novo no no 
i (Le 
Caignec et 
al., 2003) 
46,XX/46,XX,add(7q36).ish 
der(7)(q36),t(2;7)(p22;q36) 
de novo no sacrococcygeal 
teratoma 
j (Benzacken 
et al., 1997) 
(case 1) 
46,XX.ish,del(7q36) de novo semilobar 
HPE 
Sland S2 
hemivertebrae 
k (Benzacken 
et al., 1997) 
(case 4) 
46,XX,der(7)t( 1 ;7)(q41 ;q3 5) maternal alobar 
HPE 
partial sacral 
agenesis 
1 (Roessler et 
al., 1997b) 
Patient 28 
46,XX,del(7)(q3 5) no Sacral 
hypoplasia 
m Patient 1 
(this study) 
46,XX,del(7q36.2) de novo no signs partial sacral 
agenesis 
n Patient 2 
(this study) 
46,XY,del(7q35) de novo no signs no 
0 Patient 3 
(this study) 
46,XX,der(7),t(X;7)(q28;q36.1) de novo no signs no 
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Figure 1: Low-resolution (al) and high-resolution (a2) karyotypes of the patient 1, low-
resolution karyotype of patient 2 (b) and patient 3 (c) showing the terminal deletion 
(indicated with an arrow). 
Flgtmre 2; FISH with sub-telomere, 7p in Spectrum Green and 7q in Spectrum Orange for 
chromosome 7 on metaphase in patient 1 (a), patient 2 (b), patient 3 (c), Yellow 14q* and Aqua 
14ql 1.2* (locus VIJyRM2000, Vysis) (c), CEP X in Aqua, Xq/Yq in Yellow, 2p* in Green and 
2q* in Red, Xq duplication confirmed in patient 3 (locus Cdyl6c07, Vysis) (d). 
* The extra probes on chromosome 2 and 14 were present in the commercially purchased probe mix that 
was used for chromosome 7 and X, and were not hybridized on purpose. 
61 
M C F M C F M C f 
Figure 3: Example of deleted markers, D7S2465 in patient 1 (a), D7S798 in patient 2 (b) and 
D7S483 in patient 3 (c). 
Non-deleted markers, D7S483 in patient 1 (d), D7S661 in patient 2 (e) and D7S688 in patient 3 
(f). 
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Figure 4: Array-CGH analysis depicting 7q36.2 and 7q35 deletions in patients 1(a) & 2(b) 
respectively, and patient 3 depicting deletion 7q36.1(c) along with duplication Xq28 (d). 
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Figure 5: Main clinical symptoms presented by 7q35 (in green) and 7q36 (in blue) deletion 
patients. A- 9 cases with P.d*, 7 with U.t**; B- 3 cases with P.d, 2 with U.t; C- 1 case with P.d, 
10 with U.t; D- both cases with U.t; E- 1 case with P.d, 2 with U.t; F- 1 case with U.t. 
* Pure terminal deletion 
** Unbalanced translocation 
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GENERAL DISCUSSION 
Chromosomal deletions account for around 1-4.5% of all detected chromosomal 
abnormalities (Forrester et al., 2007). We reported three patients with 7q terminal deletion 
and reviewed previously published cases. The symptoms resulting from such deletions 
come under the "7q deletion syndrome" (Harris et al., 1977). The breakpoints for this 
syndrome have been variable and can range from 7q32, 7q33, 7q34, 7q35 to 7q36. We 
have confined our study to patients with 7q35 and 7q36 deletions. 
Determination of breakpoint 
Patient 1 presented developmental delay, microcephaly, dysmorphic signs, partial sacral 
agenesis and moderate hearing problems. 
Patient 2 was an aborted male fetus, 22 weeks old. Apart from slight microcephaly and 
pylectasia of the right kidney, there were no apparent malformations. No signs of HPE or 
sacral agenesis were observed. 
Patient 3 who was a 2 yr and 8 months old girl, on examination showed signs of delayed 
development and microcephaly. No other severe signs were observed, she was relatively 
normal. 
Consequently, their chromosomes were investigated. The phenotype in patient 1 was 
ascribed to the terminal deletion of the long arm of chromosome 7 i.e. deletion 7q36.2-
qter, which is relatively a rare deletion. This deletion was not detected using standard 
low-resolution karyotype and could only be seen using a high-resolution karyotype. This 
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case highlights the importance of higher resolution karyotyping in cases carrying smaller 
deletions or rearrangements, which often go unnoticed using conventional standard 
cytogenetics. Using sub-telomere FISH specific for chromosome 7, we were able to 
confirm the result of high-resolution karyotype. 
Similar procedure was followed for evaluating the patients 2 and 3, by performing 
karyotype and then sub-telomere FISH as described above. It was observed that both of 
these cases carried 7q terminal deletion. 
However, there is a limitation to these techniques and through them we were unable to 
determine the breakpoint and whether it was present on maternal or paternal chromosome. 
Therefore we used higher resolution techniques like microsatellite analysis and aCGH to 
further localize the breakpoint. 
By microsatellite analysis we were able to determine that the deletion was on the 
maternally derived chromosome in patient 1 and on paternally derived chromosomes in 
patients 2 and 3. 
In patient 1 the breakpoint roughly lay between the markers D7S483 at 151.83 Mb at 
7q36.1 and D7S798 at 152.44 Mb at 7q36.2. Consequently, it was not possible to know 
whether the deletion started at band 7q36.1 or 7q36.2, as a result determination of all the 
genes lost became difficult. Array-CGH analysis was performed to look for cryptic 
aberrations. No other anomalies were found. The result revealed the deletion started not at 
7q36.1 but at 7q36.2. Thus the patient was monosomic for region 7q36.2. 
In patient 2 the breakpoint lay between the markers D7S661 at approximately 143.20 Mb 
at 7q35 and D7S2426 at 149.10 Mb, band 7q36.1. Again the exact band at which the 
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deletion started could not be known. This was followed by aCGH to look for cryptic 
aberrations and to locate the exact band deleted. The deletion started at band 7q35 and no 
other chromosomal anomalies were reported. 
In patient 3 the deletion was localized between the markers D7S642 at approximately 
150.58 Mb and D7S483 at 151.83 Mb, band 7q36.1. The band at which the deletion 
originated was determined (7q36.1) but there was an approximately 1 Mb difference 
between the two markers, thus, aCGH was performed. It was revealed that along with the 
7q36 deletion, there was an Xq28 duplication too, which was missed by performing the 
standard karyotype. Since it was only a 1.2 Mb duplication, this size of anomaly is not 
visible using standard cytogenetics, signifying why it is important to perform aCGH and 
how it has been lately used as a discovery tool. 
Mosaicism 
A chromosome analysis of buccal smear and fibroblast cells was done in patient 1 (skin 
and buccal smear samples were not available from patients 2 and 3) to look for any 
possible mosaicism. Mosaicism is the presence of two populations of cells with different 
genotypes in an individual. Since the patient did not present any signs of HPE, it was 
hypothesized that she was probably mosaic for the deletion and that her cells other than 
blood did not have any deletion which compensated for the SHH protein loss in her blood 
cells. To verify this, sub-telomere FISH on her buccal smear cells and skin cells was 
performed specific for chromosome 7. It was observed that the deletion was also present 
in skin and buccal smear cells (Figure 18). 
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Figure 18: FISH with sub-telomere probes 7q in SO, 7p in SG, on buccal smear 
and fibroblasts cells. Only one red signal confirms deletion 7q. 
Therefore, due to the deletion, a lot of genes were missing. Some of these genes are 
crucial, required during embryological development and are especially involved' in 
neurological development. These genes were- HTR5A, EN2, SHH, LMBR1, HLXB9, and 
were found to be deleted in all the three cases. 
Comparison with the literature 
Various chromosomal deletions have been reported and described in the literature. 
Considering the cases carrying terminal deletion of the long arm of other chromosomes, it 
was observed that there are a lot of common malformations that are not chromosome 
specific but are more due to the deletion or mutation of the genes that these chromosomes 
carry. This pattern was also observed in cases with lp36 and 14q terminal deletion as 
mentioned in the introduction. For instance, some of the symptoms that were common to 
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the three syndromes (lp36, 14qter and 7q35-q36) were- microcephaly, broad nasal 
bridge, hypotonia, mental retardation and developmental delay. A lot more symptoms 
were common between lp36 and 7q35-36 deletions. In other words, various chromosomal 
deletions produce different but characteristic syndrome with some degree of overlap. 
Others common features that were noticed were, multiple congenital anomalies, 
psychomotor retardation, mental retardation, developmental delay, dysmorphism, CNS 
(central nervous system) anomalies, -agenesis/thin corpus callosum, hydrocephaly, 
hypotonia, dysphagia/feeding difficulties, microcephaly, midface hypoplasia, upslanting 
palpebral fissures, epicanthic folds, prominent forehead, hypertelorism, deep set eyes, 
broad nose/flat nasal bridge, downturned corners of the mouth, micro/retrognathia, cleft 
lip or palate, low set/dysplastic ears, clinodactyly of the 5th fingers, small hands, tapering 
finger, urogenital anomalies, minor cardiac malformation and/or moderate hearing loss 
(Evers et al., 1996; Hiraki et al., 2008; Kitsiou-Tzeli et al., 2007; Scigliano et al., 2004; 
Taysi et al., 1979; Telford et al., 1990) associated with the terminal deletion of lq, 2q, 6q, 
lOq and 14q. As a consequence, the symptoms appear to be regulated by gene products of 
various chromosomes together during the embryonic development of a human. 
Beside association with 7q36 deletion, HPE has been found in 70% infants with trisomy 
13, but is also associated with trisomy 18 and triploidy (Gurrieri et al., 1993). The 
following chromosome anomalies are also non-randomly associated with HPE; del(18p), 
dup(3)(p24-pter), del(2)(p21), and del(21)(q22.3) (Gurrieri et al., 1993). Mothers with 
diabetes have an increased incidence of bearing a child with brain anomalies (Cohen 
1989). Mutation of some genes such as ZIC2, SIX3, TGIF, PTCH, GLI2, FASTI, 
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TDGF1, and DHCR7 is also known to result in HPE (Cohen 2006). 
However none of the cases that we present here had HPE and only one patient had right 
kidney pyelectasis. These three cases give an interesting insight into the "variability of 
symptoms" presented by different 7q deletion carriers. Apparently, the case with the 
smallest deletion (7q36.2-qter) (Case 1) had sacral agenesis. The case with the largest 
deletion (7q35-qter) (Case 2) among the three had minimal symptoms. And the 3rd case 
(Case 3) with a translocation did not present any severe symptoms too. 
Lukusa and colleagues (Lukusa et al., 2005) reviewed 10 cases with 7q35 deletion and 30 
cases with 7q36 deletion. Out of these 30 cases, nine presented with HPE (Borovik C. L. 
1987; Burrig et al., 1989; Chen et al., 1999; Chen et al., 1996; Grass F.S. 1995) (patient 
3), (Kleczkowska et al., 1990; Kurtzman et al., 1987; Morichon-Delvallez et al., 1993; 
Nowaczyk et al., 2000), all these patients carried an unbalanced translocation. Eleven 
cases had sacral malformations, five cases with pure terminal deletion (Frints et al., 1998) 
(patient 2), (Masuno et al., 1990; Petrusevska 1996; Rodriguez et al., 2002), and six cases 
with unbalanced translocations (Morichon-Delvallez et al., 1993; Nowaczyk et al., 2000; 
Savage et al., 1997; Wang et al., 1999). In the above cases, both HPE and sacral 
malformation in association were present in only two of them (Morichon-Delvallez et al., 
1993; Nowaczyk et al., 2000). 
For a total of 10 cases with 7q35 deletion, only one patient had HPE (Vance et al., 1998) 
(patient V-I); this case had an unbalanced translocation between chromosome 3 and 7 
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resulting in monosomy 7q35 and trisomy 3p22. Three patients presented with sacral 
malformation, two with pure terminal deletion (Masuno et al., 1996; Turleau et al., 1979) 
and one with an unbalanced translocation (Shaffer et al., 1996). HPE and sacral 
malformations together were not seen in any case. 
A total of 15 cases are described in table 2, including our three cases. Three patients were 
with 7q35 deletion and twelve with 7q36 deletion. In 7q36 deletion patients, only two 
carried HPE, one with an unbalanced rearrangement (c) and another with pure terminal 
deletion (j). Sacral malformations were observed in five patients, four of which were pure 
deletions (a, e, j, m) and one was an unbalanced rearrangement (i). Together HPE and 
sacral anomalies were observed in one patient (j) only. Out of the three cases of 7q35 
deletion, one presented with HPE (k), with an unbalanced translocation; two carried 
sacral malformations, one with pure deletion (1) and other with an unbalanced 
translocation (k). Patient k presented both HPE and sacral malformation in association. 
Summarizing the data in figure 5 from Lukusa's review and table 2, we got forty two 
7q36 and thirteen 7q35 terminal deletion cases (figure 5), a total of 55 cases. We observed 
that severe forms of HPE were found in patients with unbalanced translocation, meaning, 
monosomy of 7qter region and trisomy of terminal region of some other chromosome 
(figure 5: C, D). It was also observed that both sacral agenesis and HPE in association 
were present in less than 10% of the cases (E,F). Sacral malformation was observed in 
approximately 38% of the cases reported in both 7q35 and 7q36 deletion (A,B) 
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Severe phenotype in unbalanced translocation and pure terminal deletion cases was 
probably due to loss of genetic material (and may be extra dosage of genes in case of 
partial trisomy). A balanced translocation implies no loss or gain of genetic material, yet 
some cases had an abnormal phenotype ascribed to position effect. A minimal critical 
region for the locus HPE3 (gene SHH) was refined by analyzing 34 cell lines (Roessler et 
al., 1997b). In some instances with patients carrying a balanced translocation between 
chromosome 7 and other chromosome, even when the gene SHH was intact i.e. the 
breakpoint was outside the putative gene, some cases did present HPE (Roessler et al., 
1997b). This is termed as position effect. Position effect can be defined as a harmful 
change in the level of gene expression through long-range effects on chromatin structure 
or by disruption of regulatory elements. 
However the cause of the variability of symptoms was unclear. The DNA sequence of 
two unrelated individuals is almost 99.9% identical. The rest of the DNA contains 
variations called as polymorphism. Polymorphisms in the coding region of DNA are of 
much importance and imply a significant function. It has the ability to affect the response 
to drugs and to influence the severity of a disease. There can be an existence of multiple 
alleles at a locus, each with a different effect on the phenotype. These alleles possess 
different mutations that alter the protein function, thus producing changes in phenotype. 
It is also possible that there are some genetic modifiers of the genes SHH and HLXB9 
which alter the expression of these genes resulting in heterogeneous phenotypes. Modifier 
genes are the genes that affect the gene expression of the target genes. Polymorphism in 
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the modifier genes may also result in altered expression. Single Nucleotide 
Polymorphisms (SNPs) are single base pair positions in the genome at which variation in 
nucleotide gives rise to alternative alleles in normal individuals and populations (Brookes 
1999). An SNP in the promoter region of the modifier gene will affect the transcription 
rate, in an exon will affect the protein structure or function, and an SNP within the intron 
will interfere with the splicing (Brookes 1999). 
Conclusion 
Utilizing various conventional and molecular cytogenetic techniques we were able to 
extensively and accurately characterize the deletion in our patients. It was performed in a 
step-by-step manner, advancing from low-resolution to high-resolution analysis. This was 
followed by a careful and thorough review of the literature with 7q terminal deletion 
cases which assisted us in resolving the apparent cause of the variable phenotypes. 
We propose a possible existence and role of genetic modifiers along with polymorphism 
and various environmental factors as an explanation for this kind of pattern. In some 
cases, perhaps the gene product is balanced by the expression of the genes from intact 
homologous chromosome resulting in milder phenotype. 
An extensive study in this regard including a large number of patients is required to 
validate this theory. It is important to note here that the evaluation of chromosome 7 will 
be helpful in patients who show signs of caudal agenesis or HPE, even though these 
symptoms were not very frequently seen. Furthermore, a high-resolution analysis like 
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aCGH should be encouraged for cases with miscellaneous symptoms where there is no 
previous knowledge of the anomaly. 
Patients with an unbalanced translocation involving monosomy of 7qter region should be 
evaluated more carefully since they are more likely to present with severe forms of HPE. 
Even though sacral agenesis and HPE have always been linked with 7qter deletion, we 
found that these symptoms were present in association in only less than 10% of the cases. 
The next step in this regard would be to perform array-expression in future cases with this 
deletion to study polymorphism and protein products. Further research is likely to 
improve our understanding on how certain genetic modifiers and polymorphisms result in 
heterogeneous phenotypes, along with the effects of "gene-environment interactions". 
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